Any feedback?
Please rate this page
(sequences.php)
(0/150)

BRENDA support

Sequence of PGDH_HUMAN

EC Number:1.1.1.232

EC Number
Recommended Name
Accession Code
Organism
No of amino acids
Molecular Weight [Da]
Source
15-hydroxyicosatetraenoate dehydrogenase
P15428
Homo sapiens
266
28977
Reaction
(15S)-15-hydroxy-5,8,11-cis-13-trans-icosatetraenoate + NAD(P)+ = 15-oxo-5,8,11-cis-13-trans-icosatetraenoate + NAD(P)H + H+
Other sequences found for EC No. 1.1.1.232

General information:

Sequence
show sequence in fasta format
  0 MHVNGKVALV TGAAQGIGRA FAEALLLKGA KVALVDWNLE AGVQCKAALD EQFEPQKTLF
 60 IQCDVADQQQ LRDTFRKVVD HFGRLDILVN NAGVNNEKNW EKTLQINLVS VISGTYLGLD
120 YMSKQNGGEG GIIINMSSLA GLMPVAQQPV YCASKHGIVG FTRSAALAAN LMNSGVRLNA
180 ICPGFVNTAI LESIEKEENM GQYIEYKDHI KDMIKYYGIL DPPLIANGLI TLIEDDALNG
240 AIMKITTSKG IHFQDYDTTP FQAKTQ
Download this sequence
in fasta format
Download all sequences for 1.1.1.232
in fasta format
in csv (Excel, OpenOffice) format
Sequence related references
Sequence Reference
Authors
Title
Journal
Volume
Pages
Year
PubMed ID
585379
Krook M.,Marekov L.,Joernvall H.
Purification and structural characterization of placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase. The primary structure reveals the enzyme to belong to the short-chain alcohol dehydrogenase family.
Biochemistry
29
738-743
1990
585380
Ensor C.M.,Yang J.Y.,Okita R.T.,Tai H.-H.
Cloning and sequence analysis of the cDNA for human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
J. Biol. Chem.
265
14888-14891
1990
585381
Pichaud F.,Frendo J.L.,Delage-Mourroux R.,de Vernejoul M.C.,Moukhtar M.S.,Jullienne A.
Sequence of a novel mRNA coding for a C-terminal-truncated form of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
Gene
162
319-322
1995
585382
Delage-Mourroux R.,Pichaud F.,Frendo J.L.,Pidoux E.,Guliana J.M.,Moukhtar M.S.,Jullienne A.
Cloning and sequencing of a new 15-hydroxyprostaglandin dehydrogenase related mRNA.
Gene
188
143-148
1997
585383
Ota T.,Suzuki Y.,Nishikawa T.,Otsuki T.,Sugiyama T.,Irie R.,Wakamatsu A.,Hayashi K.,Sato H.,Nagai K.,Kimura K.,Makita H.,Sekine M.,Obayashi M.,Nishi T.,Shibahara T.,Tanaka T.,Ishii S.,Yamamoto J.,Saito K.,Kawai Y.,Isono Y.,Nakamura Y.,Nagahari K.,Murakami K.,Yasuda T.,Iwayanagi T.,Wagatsuma M.,Shiratori A.,Sudo H.,Hosoiri T.,Kaku Y.,Kodaira H.,Kondo H.,Sugawara M.,Takahashi M.,Kanda K.,Yokoi T.,Furuya T.,Kikkawa E.,Omura Y.,Abe K.,Kamihara K.,Katsuta N.,Sato K.,Tanikawa M.,Yamazaki M.,Ninomiya K.,Ishibashi T.,Yamashita H.,Murakawa K.,Fujimori K.,Tanai H.,Kimata M.,Watanabe M.,Hiraoka S.,Chiba Y.,Ishida S.,Ono Y.,Takiguchi S.,Watanabe S.,Yosida M.,Hotuta T.,Kusano J.,Kanehori K.,Takahashi-Fujii A.,Hara H.,Tanase T.-O.,Nomura Y.,Togiya S.,Komai F.,Hara R.,Takeuchi K.,Arita M.,Imose N.,Musashino K.,Yuuki H.,Oshima A.,Sasaki N.,Aotsuka S.,Yoshikawa Y.,Matsunawa H.,Ichihara T.,Shiohata N.,Sano S.,Moriya S.,Momiyama H.,Satoh N.,Takami S.,Terashima Y.,Suzuki O.,Nakagawa S.,Senoh A.,Mizoguchi H.,Goto Y.,Shimizu F.,Wakebe H.,Hishigaki H.,Watanabe T.,Sugiyama A.,Takemoto M.,Kawakami B.,Yamazaki M.,Watanabe K.,Kumagai A.,Itakura S.,Fukuzumi Y.,Fujimori Y.,Komiyama M.,Tashiro H.,Tanigami A.,Fujiwara T.,Ono T.,Yamada K.,Fujii Y.,Ozaki K.,Hirao M.,Ohmori Y.,Kawabata A.,Hikiji T.,Kobatake N.,Inagaki H.,Ikema Y.,Okamoto S.,Okitani R.,Kawakami T.,Noguchi S.,Itoh T.,Shigeta K.,Senba T.,Matsumura K.,Nakajima Y.,Mizuno T.,Morinaga M.,Sasaki M.,Togashi T.,Oyama M.,Hata H.,Watanabe M.,Komatsu T.,Mizushima-Sugano J.,Satoh T.,Shirai Y.,Takahashi Y.,Nakagawa K.,Okumura K.,Nagase T.,Nomura N.,Kikuchi H.,Masuho Y.,Yamashita R.,Nakai K.,Yada T.,Nakamura Y.,Ohara O.,Isogai T.,Sugano S.
Complete sequencing and characterization of 21,243 full-length human cDNAs.
Nat. Genet.
36
40-45
2004
585385
Hillier L.W.,Graves T.A.,Fulton R.S.,Fulton L.A.,Pepin K.H.,Minx P.,Wagner-McPherson C.,Layman D.,Wylie K.,Sekhon M.,Becker M.C.,Fewell G.A.,Delehaunty K.D.,Miner T.L.,Nash W.E.,Kremitzki C.,Oddy L.,Du H.,Sun H.,Bradshaw-Cordum H.,Ali J.,Carter J.,Cordes M.,Harris A.,Isak A.,van Brunt A.,Nguyen C.,Du F.,Courtney L.,Kalicki J.,Ozersky P.,Abbott S.,Armstrong J.,Belter E.A.,Caruso L.,Cedroni M.,Cotton M.,Davidson T.,Desai A.,Elliott G.,Erb T.,Fronick C.,Gaige T.,Haakenson W.,Haglund K.,Holmes A.,Harkins R.,Kim K.,Kruchowski S.S.,Strong C.M.,Grewal N.,Goyea E.,Hou S.,Levy A.,Martinka S.,Mead K.,McLellan M.D.,Meyer R.,Randall-Maher J.,Tomlinson C.,Dauphin-Kohlberg S.,Kozlowicz-Reilly A.,Shah N.,Swearengen-Shahid S.,Snider J.,Strong J.T.,Thompson J.,Yoakum M.,Leonard S.,Pearman C.,Trani L.,Radionenko M.,Waligorski J.E.,Wang C.,Rock S.M.,Tin-Wollam A.-M.,Maupin R.,Latreille P.,Wendl M.C.,Yang S.-P.,Pohl C.,Wallis J.W.,Spieth J.,Bieri T.A.,Berkowicz N.,Nelson J.O.,Osborne J.,Ding L.,Meyer R.,Sabo A.,Shotland Y.,Sinha P.,Wohldmann P.E.,Cook L.L.,Hickenbotham M.T.,Eldred J.,Williams D.,Jones T.A.,She X.,Ciccarelli F.D.,Izaurralde E.,Taylor J.,Schmutz J.,Myers R.M.,Cox D.R.,Huang X.,McPherson J.D.,Mardis E.R.,Clifton S.W.,Warren W.C.,Chinwalla A.T.,Eddy S.R.,Marra M.A.,Ovcharenko I.,Furey T.S.,Miller W.,Eichler E.E.,Bork P.,Suyama M.,Torrents D.,Waterston R.H.,Wilson R.K.
Generation and annotation of the DNA sequences of human chromosomes 2 and 4.
Nature
434
724-731
2005
585387
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Genome Res.
14
2121-2127
2004
585388
Ensor C.M.,Tai H.-H.
Site-directed mutagenesis of the conserved tyrosine 151 of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase yields a catalytically inactive enzyme.
Biochem. Biophys. Res. Commun.
176
840-845
1991
585389
Ensor C.M.,Tai H.H.
Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
Biochim. Biophys. Acta
1208
151-156
1994
585390
Clish C.B.,Levy B.D.,Chiang N.,Tai H.-H.,Serhan C.N.
Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation.
J. Biol. Chem.
275
25372-25380
2000
585391
Patel F.A.,Funder J.W.,Challis J.R.G.
Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at term.
J. Clin. Endocrinol. Metab.
88
2922-2933
2003
585392
Nomura T.,Lu R.,Pucci M.L.,Schuster V.L.
The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase.
Mol. Pharmacol.
65
973-978
2004
585393
Yan M.,Rerko R.M.,Platzer P.,Dawson D.,Willis J.,Tong M.,Lawrence E.,Lutterbaugh J.,Lu S.,Willson J.K.V.,Luo G.,Hensold J.,Tai H.-H.,Wilson K.,Markowitz S.D.
15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
Proc. Natl. Acad. Sci. U.S.A.
101
17468-17473
2004
585394
Cho H.,Huang L.,Hamza A.,Gao D.,Zhan C.-G.,Tai H.-H.
Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2.
Bioorg. Med. Chem.
14
6486-6491
2006
585395
Arita M.,Oh S.F.,Chonan T.,Hong S.,Elangovan S.,Sun Y.P.,Uddin J.,Petasis N.A.,Serhan C.N.
Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions.
J. Biol. Chem.
281
22847-22854
2006
585396
Liu X.,Zhang S.,Arora J.S.,Snyder N.W.,Shah S.J.,Blair I.A.
11-Oxoeicosatetraenoic acid is a cyclooxygenase-2/15-hydroxyprostaglandin dehydrogenase-derived antiproliferative eicosanoid.
Chem. Res. Toxicol.
24
2227-2236
2011
585397
Claria J.,Dalli J.,Yacoubian S.,Gao F.,Serhan C.N.
Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat.
J. Immunol.
189
2597-2605
2012
585398
Wendell S.G.,Golin-Bisello F.,Wenzel S.,Sobol R.W.,Holguin F.,Freeman B.A.
15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy omega-3 fatty acids.
J. Biol. Chem.
290
5868-5880
2015
585399
Krook M.,Ghosh D.,Duax W.L.,Joernvall H.
Three-dimensional model of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase and relationships to the NADP(+)-dependent enzyme (carbonyl reductase).
FEBS Lett.
322
139-142
1993
585400
Uppal S.,Diggle C.P.,Carr I.M.,Fishwick C.W.G.,Ahmed M.,Ibrahim G.H.,Helliwell P.S.,Latos-Bielenska A.,Phillips S.E.V.,Markham A.F.,Bennett C.P.,Bonthron D.T.
Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy.
Nat. Genet.
40
789-793
2008
585402
Niesen F.H.,Schultz L.,Jadhav A.,Bhatia C.,Guo K.,Maloney D.J.,Pilka E.S.,Wang M.,Oppermann U.,Heightman T.D.,Simeonov A.
High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships.
PLoS ONE
5
0-0
2010
585403
Tariq M.,Azeem Z.,Ali G.,Chishti M.S.,Ahmad W.
Mutation in the HPGD gene encoding NAD+ dependent 15-hydroxyprostaglandin dehydrogenase underlies isolated congenital nail clubbing (ICNC).
J. Med. Genet.
46
14-20
2009